Copyright © 2002 by the European Society of Cardiology.
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease
a Department of Cardiology, Catholic University, Rome, Italy
b Department of Haematology, Catholic University, Rome, Italy
revised February 23, 2001; accepted February 28, 2001
Abstract
Aims To investigate the prevalence of the G20210A prothrombin and G1691A factor V gene variants in patients with acute coronary syndrome stratified according to risk factor profile and to extent of coronary disease, in comparison with matched healthy controls.
Methods and Results The 20210 prothrombin and the 1691 factor V loci were genotyped in 247 patients 
65 years of age (190 myocardial infarction and 57 unstable angina as first presentation of disease) and in 247 healthy age- and sex-matched controls. The prevalence of the 1691A factor V allele was similar in cases and controls. The frequency of heterozygotes for the 20210A prothrombin allele was 6·5% among patients and 2·8% among controls (OR 2·4, 95% CI 1·0–5·9), increasing to 8·7% in patients with a family history of myocardial infarction (OR 3·3, 95% CI 1·2–9·1), to 9·9% in patients (n=81) with 1 vessel disease (OR 3·8, 95% CI 1·3–10·8), and to 13·0% in patients who were normocholesterolaemic, non-diabetic, normotensive and non-smokers (OR 5·1, 95% CI 1·2–21·4).
Conclusions These findings suggest that the 20210A prothrombin allele represents an inherited risk factor for acute coronary syndrome among patients who have limited extent of coronary disease at angiography or who lack major metabolic and acquired risk factors.
Key Words: Genetic polymorphism, prothrombin, acute coronary syndrome, risk factors
f1 Correspondence: Francesco Burzotta, MD, Institute of Cardiology, Catholic University, Largo Gemelli 8, 00168 Rome, Italy.
References
- Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703
[Abstract/Free Full Text] - Ferraresi P, Marchetti G, Legnani C. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol. 1997;17:2418–2422
[Abstract/Free Full Text] - Franco RF, Trip MD, ten Cate H. The 20210 G
A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol. 1999;104:50–54[CrossRef][ISI][Medline]
- Bertina RM. The prothrombin 20210 G to A variation and thrombosis. Curr Opin Hematol. 1998;5:339–342[Medline]
- Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood. 1997;90:1747–1750
[Abstract/Free Full Text] - Corral J, Gonzalez-Conejero R, Lozano ML, Rivera J, Heras I, Vicente V. The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol. 1997;99:304–307[CrossRef][ISI][Medline]
- Eikelboom JW, Baker RI, Parsons R, Taylor RR, van Bockxmeer FM. No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost. 1998;80:878–880[ISI][Medline]
- Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost. 1997;78:1430–1433[ISI][Medline]
- Arruda VR, Siquiera LH, Chiaparini LC. Prevalence of the prothrombin gene variant 20210 GA among patients with myocardial infarction. Cardiovasc Res. 1998;37:42–45
[Abstract/Free Full Text] - Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation. 1998;97:1037–1041
[Abstract/Free Full Text] - Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999–1004
[Abstract/Free Full Text] - Vargas M, Soto I, Pinto CR. The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease. Blood Coagul Fibrinolysis. 1999;10:39–41[ISI][Medline]
- Prohaska W, Schmidt M, Mannebach H, Gleichmann U, Kleesiek K. The prevalence of the prothrombin 20210 GA mutation is not increased in angiographically confirmed coronary artery disease (letter). Thromb Haemost. 1999;81:161–162[ISI][Medline]
- Gardemann A, Arsic T, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W. The factor II G20210A and factor V G1691A gene transitions and coronary heart disease. Thromb Haemost. 1999;81:208–213[ISI][Medline]
- Croft SA, Daly ME, Steeds RP, Channer KS, Samani NJ, Hampton KK. The prothrombin 20210A allele and its association with myocardial infarction. Thromb Haemost. 1999;81:861–864[ISI][Medline]
- Inbal A, Freimark D, Modan B. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood. 1999;93:2186–2190
[Abstract/Free Full Text] - Ardissino D, Mannucci PM, Merlini PA. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood. 1999;94:46–51
[Abstract/Free Full Text] - Bertina RM, Koeleman BPC, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67[CrossRef][Medline]
- De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Haemost. 1998;24:367–379[ISI][Medline]
- Bothig S. WHO MONICA project: objectives and design. Int J Epidemiol. 1989;18:S29–S37[Abstract]
- Braunwald E. Unstable angina: a classification. Circulation. 1989;80:410–414
[Free Full Text] - De Stefano V, Chiusolo P, Paciaroni K. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;91:3562–3565
[Abstract/Free Full Text] - Burzotta F, Paciaroni K, Andreotti F, Casorelli I, De Stefano V. G20210A prothrombin gene polymorphism and extent of coronary disease. Thromb Haemost. 2000;84:142–143[ISI][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Andreotti and R. C. Becker Atherothrombotic Disorders: New Insights From Hematology Circulation, April 12, 2005; 111(14): 1855 - 1863. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pullmann Jr, M. Skerenova, J. Lukac, J. Hybenova, V. Melus, P. Kubisz, J. Rovensky, and R. Pullmann Factor V Leiden and Prothrombin G20210A Mutations and the Risk of Atherothrombotic Events in Systemic Lupus Erythematosus Clinical and Applied Thrombosis/Hemostasis, July 1, 2004; 10(3): 233 - 238. [Abstract] [PDF]
|
|
|
|
 |
|
 F Burzotta, K Paciaroni, V De Stefano, F Crea, A Maseri, G Leone, and F Andreotti G20210A Prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects Heart, January 1, 2004; 90(1): 82 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Burzotta, M Hamon, R Sabatier, F Prati, A Boccanelli, and G Grollier Large intracoronary thrombi with good TIMI flow during acute myocardial infarction: four cases of successful aggressive medical management in patients without angiographically detectable coronary atherosclerosis Heart, December 1, 2002; 88(5): e6 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Pollak, H.-S. Lam, and J. E. Russell The G20210A mutation does not affect the stability of prothrombin mRNA in vivo Blood, June 17, 2002; 100(1): 359 - 362. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||